Showing results (261-270 of 1,016) with videos related to

Sort By:
Pageof 102
Journal of Clinical Medicine|October 19, 2019
NK Cell-Based Immunotherapy for Hematological MalignanciesSimona Sivori, Raffaella Meazza, Concetta Quintarelli, et al.
Haematologica|March 15, 2006
Prognostic value of donor cytotoxic T-lymphocyte precursor frequencies for acute graft-versus-host disease in hematopoietic stem cell transplantation from HLA-matched siblings: a single center experience in a cohort of 92 patientsFederico Sizzano, Paola Magistroni, Franco Locatelli, et al.
Blood|January 24, 2004
Atypical features of familial hemophagocytic lymphohistiocytosisRosanna Busiello, Marsilio Adriani, Franco Locatelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2013
Neuroblastoma-derived TGF-β1 modulates the chemokine receptor repertoire of human resting NK cellsRoberta Castriconi, Alessandra Dondero, Francesca Bellora, et al.
Cancers|October 17, 2020
GATA2 Related Conditions and Predisposition to Pediatric Myelodysplastic SyndromesAntonella Bruzzese, Davide Leardini, Riccardo Masetti, et al.
International Journal of Molecular Sciences|March 3, 2019
CB2 Receptor Stimulation and Dexamethasone Restore the Anti-Inflammatory and Immune-Regulatory Properties of Mesenchymal Stromal Cells of Children with Immune ThrombocytopeniaFrancesca Rossi, Chiara Tortora, Giuseppe Palumbo, et al.
Frontiers in Immunology|June 6, 2018
Late Development of FcεRγneg Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation RecipientsLetizia Muccio, Michela Falco, Alice Bertaina, et al.
Stem Cells and Development|June 18, 2014
Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitroAntonella Conforti, Marco Scarsella, Nadia Starc, et al.
Therapeutic Advances in Hematology|October 12, 2023
Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomabHagop M Kantarjian, Aaron C Logan, Faraz Zaman, et al.
Scientific Reports|October 27, 2017
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastomaValentina Rigo, Laura Emionite, Antonio Daga, et al.
Pageof 102